Immunogenicity For Biotherapeutics

Advance Risk Assessment Strategies and Optimize the Prediction of Immune Response to Accelerate the Process from Concept to Approval

WCBNoTag

Improve your drug safety analysis with improved,
specific, and accurate immunogenicity information
so you can minimize the time it takes to gain
regulatory approval and increase speed to market


  • Hear firsthand perspectives from the FDA to gain insights and ask your questions to accelerate the approval process
  • Collaborate with peers and industry experts to develop solutions for predicting, anticipating, and mitigating risks created by potential immune responses
  • Discover cutting-edge technologies to improve immunogenicity testing
  • Improve the accuracy of your risk assessment by understanding how protein aggregation impacts immunogenic responses

Download Your
Copy Today!



B15193minibrochure


“An excellent program – extremely useful from a technical
perspective. The lessons from the case studies and discussions
will assist our group’s development efforts.”
– Thomas Klem, Scientist, Shire

 


Use Priority Code IMMUNO15BDS to Save 20%


Group Savings Available for Companies Registering 4+ Attendees

Register Now